WallStSmart

Coca-Cola Femsa SAB de CV ADR (KOF)vsMondelez International Inc (MDLZ)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola Femsa SAB de CV ADR generates 664% more annual revenue ($304.95B vs $39.90B). MDLZ leads profitability with a 10.2% profit margin vs 8.0%. MDLZ appears more attractively valued with a PEG of 0.96. MDLZ earns a higher WallStSmart Score of 70/100 (B-).

KOF

Hold

46

out of 100

Grade: D+

Growth: 6.0Profit: 6.0Value: 4.7Quality: 5.5
Piotroski: 3/9Altman Z: 2.47

MDLZ

Strong Buy

70

out of 100

Grade: B-

Growth: 6.7Profit: 6.5Value: 5.3Quality: 4.5
Piotroski: 3/9Altman Z: 1.61
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KOFUndervalued (+60.8%)

Margin of Safety

+60.8%

Fair Value

$287.29

Current Price

$114.43

$172.86 discount

UndervaluedFair: $287.29Overvalued
MDLZSignificantly Overvalued (-19.6%)

Margin of Safety

-19.6%

Fair Value

$51.40

Current Price

$66.02

$14.62 premium

UndervaluedFair: $51.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KOF2 strengths · Avg: 8.0/10
Price/BookValuation
3.0x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$8.86B8/10

Generating 8.9B in free cash flow

MDLZ4 strengths · Avg: 8.8/10
EPS GrowthGrowth
78.9%10/10

Earnings expanding 78.9% YoY

Market CapQuality
$82.20B9/10

Large-cap with strong market position

PEG RatioValuation
0.968/10

Growing faster than its price suggests

Operating MarginProfitability
20.4%8/10

Strong operational efficiency at 20.4%

Areas to Watch

KOF4 concerns · Avg: 2.5/10
Profit MarginProfitability
8.0%3/10

8.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
20.632/10

Expensive relative to growth rate

P/E RatioValuation
141.9x2/10

Premium valuation, high expectations priced in

MDLZ3 concerns · Avg: 3.7/10
Revenue GrowthGrowth
2.3%4/10

2.3% revenue growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : KOF

The strongest argument for KOF centers on Price/Book, Free Cash Flow. Revenue growth of 10.9% demonstrates continued momentum.

Bull Case : MDLZ

The strongest argument for MDLZ centers on EPS Growth, Market Cap, PEG Ratio. PEG of 0.96 suggests the stock is reasonably priced for its growth.

Bear Case : KOF

The primary concerns for KOF are Profit Margin, Piotroski F-Score, PEG Ratio. A P/E of 141.9x leaves little room for execution misses.

Bear Case : MDLZ

The primary concerns for MDLZ are Revenue Growth, Altman Z-Score, Piotroski F-Score.

Key Dynamics to Monitor

KOF carries more volatility with a beta of 0.54 — expect wider price swings.

KOF is growing revenue faster at 10.9% — sustainability is the question.

KOF generates stronger free cash flow (8.9B), providing more financial flexibility.

Monitor BEVERAGES - NON-ALCOHOLIC industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDLZ scores higher overall (70/100 vs 46/100). KOF offers better value entry with a 60.8% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola Femsa SAB de CV ADR

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola FEMSA, SAB de CV, a franchise bottler, produces, markets, sells and distributes Coca-Cola brand beverages. The company is headquartered in Mexico City, Mexico.

Visit Website →

Mondelez International Inc

CONSUMER DEFENSIVE · CONFECTIONERS · USA

Mondelez International, Inc. is an American multinational confectionery, food, holding and beverage and snack food company based in Chicago, Illinois.

Visit Website →

Want to dig deeper into these stocks?